UCB's Global Corporate Website

This section is intended for media and financial analysts

Search Press releases

10 Nov 2006

UCB ANNOUNCES COMMENCEMENT OF ACCEPTANCE PERIOD FOR TAKEOVER OF SCHWARZ PHARMA

Read More
7 Nov 2006

UCB EXPANDS TO CANADA

Read More
23 Oct 2006

New Analysis Shows CIMZIA(TM) (Certolizumab Pegol) Maintained Remission and Response in Recent Onset Crohn's Disease

Read More
23 Oct 2006

New Efficacy Data Show CIMZIA(TM) (Certolizumab Pegol) Maintained Response and Remission in Crohn's Patients Previously Treated With Infliximab

Read More
23 Oct 2006

UCB Extraordinary Shareholders' General Meeting Approved Capital Increase

Read More
3 Oct 2006

UCB and Jazz Pharmaceuticals announce expansion of Xyrem® license agreement to include fibromyalgia syndrome

Read More

Stay up-to-date on the latest news and information from UCB